Us Bancorp \De\ Capricor Therapeutics, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 7,515 shares of CAPR stock, worth $99,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,515
Previous 7,462
0.71%
Holding current value
$99,122
Previous $113,000
7.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
133Shares Held
16MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$30 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$29.7 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$29.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$21.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$11.6 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $321M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...